Form 8-K - Current report:
SEC Accession No. 0001493152-24-042546
Filing Date
2024-10-25
Accepted
2024-10-25 17:00:28
Documents
13
Period of Report
2024-10-18
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40915
  Complete submission text file 0001493152-24-042546.txt   219505

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE mgrx-20241018.xsd EX-101.SCH 3033
3 XBRL LABEL FILE mgrx-20241018_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE mgrx-20241018_pre.xml EX-101.PRE 24177
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3808
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 241397728
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)